Metformin and Longevity: What the Evidence Actually Shows

A large observational study published in Lancet Diabetes and Endocrinology found that people with type 2 diabetes who were initiated on metformin had fifteen percent lower all-cause mortality than matched non-diabetic controls — a result so counterintuitive it launched a decade of research into whether metformin might extend healthy lifespan in people without diabetes. Understanding why that finding is genuinely intriguing, and why it cannot be interpreted as evidence to take metformin without a diabetes diagnosis, is what this video is about. In 2014, Lancet Diabetes and Endocrinology published a study using the UK Clinical Practice Research Datalink — one of the world's largest primary care databases — to compare mortality between seventy-eight thousand two hundred and forty-one people with type 2 diabetes initiating metformin, twelve thousand two hundred and seventy-two people with type 2 diabetes initiating a different drug class called sulphonylureas, and matched non-diabetic controls. The result that captured attention: metformin initiators had fifteen percent lower all-cause mortality than matched non-diabetics. People with a --- Paper cited: Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls Authors: Bannister CA, Holden SE, Jenkins-Jones S, Morgan CL, Halcox JP, Schernthaner G, Mukherjee J, Currie CJ Journal: Lancet Diabetes & Endocrinology Year: 2014 DOI: 10.1016/S2213-8587(14)70072-2 --- Subscribe for one peer-reviewed paper made practical, every Tuesday and Friday. Free guide: How to Read Your Biomarker Panel at 55+ - {{LEAD_MAGNET_URL}} --- EDUCATIONAL CONTENT - NOT MEDICAL ADVICE This video is for general educational and informational purposes only. It summarizes peer-reviewed research. It does NOT constitute: - Medical advice, diagnosis, or treatment - Recommendations to start, stop, or change any medication - Dosing instructions for supplements or interventions - A substitute for consultation with a licensed physician Before applying anything discussed: - Talk to your physician, especially if you take prescription medications (statins, metformin, blood thinners, antihypertensives, GLP-1 agonists, etc.) - Discuss interactions, contraindications, and your individual risk profile - Get baseline biomarkers before changing your regimen if relevant Specific cautions: - Intermittent fasting: not appropriate for people with diabetes (especially Type 1), history of eating disorders, pregnancy, or underweight status without medical supervision. - Strength/Zone-2 training: medical clearance recommended for cardiovascular or joint conditions before initiating new training loads. - Supplements: third-party tested products preferred; verify drug interactions. AFFILIATE DISCLOSURE (FTC compliant): Some links in the description may be affiliate links. We may earn a commission at no additional cost to you. We only feature products and tools relevant to the research discussed. AI-ASSISTED PRODUCTION: Voice narration is generated via Edge TTS (Microsoft Neural Voice). Research, scriptwriting, and review are conducted by a human editor before publication. Reviewed: 2026-09-02